NCT02319447

Brief Summary

For most patients with kidney failure, living donor kidney transplant (LDKT) is their best treatment option. Unfortunately, Blacks (vs. non-Blacks) are more likely to have kidney failure but less likely to receive LDKTs. In this study, the investigators will test an intervention designed to address this disparity, by performing a parallel group, two-arm randomized clinical trial among 500 Black kidney transplant candidates. The main objective of this study is to test an educational and behavioral intervention that is designed to increase receipt of LDKT among transplant candidates (persons active on the deceased donor kidney transplant waiting list) who are Black. Our overall hypothesis is that a multi-component intervention administered to Black transplant candidates will increase both readiness to pursue LDKT and actual receipt of LDKTs. The investigators will randomly assign kidney transplant candidates on the kidney transplant waiting list to either: (1) a control group that will receive Usual Care, or (2) an Intervention group that will receive a group-based intervention, as well as monthly mailings and a follow-up phone call by a transplant educator.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 18, 2014

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

December 27, 2019

Status Verified

December 1, 2019

Enrollment Period

3.2 years

First QC Date

December 15, 2014

Last Update Submit

December 23, 2019

Conditions

Keywords

Living DonationKidney Transplantation

Outcome Measures

Primary Outcomes (1)

  • Change in readiness to pursue LDKT at 9 months

    Our primary outcome is the proportion of study participants with an increase in their readiness to pursue LDKT. Readiness to pursue LDKT is assessed by the patient's Stage of Change regarding pursuing live donation, based upon James Prochaska's Transtheoretical Model. The Stages of Change regarding pursuit of living donation include: not considering (Pre-contemplation), considering (Contemplation), preparing to pursue (Preparation), or taking action to pursue (Action) living donation within the next 6 months. Stage of Change will be assessed at baseline and at 9 months post-baseline.

    Baseline, 9 months

Secondary Outcomes (4)

  • Receipt of a LDKT

    18 months

  • Number of donor volunteers recruited and evaluated

    18 months

  • Status on kidney transplant waiting list

    18 months

  • Change in knowledge of LDKT at 9 months

    Baseline, 9 months

Other Outcomes (2)

  • Change in knowledge of LDKT at 1 week post-intervention

    Baseline, 1 week post-intervention

  • Change in readiness to pursue LDKT at 1 week post-intervention

    Baseline, 1 week post-intervention

Study Arms (2)

Usual Care

NO INTERVENTION

After randomization, these study participants will receive the Usual Care received by all listed kidney transplant candidates at our center.

Additional education

EXPERIMENTAL

These study participants will be invited to attend a 60-90 minute educational seminar, entitled Destination: Transplant, delivered in a group setting. They will also receive monthly mailings for 9 months and a follow-up phone call from a transplant educator.

Behavioral: Additional education

Interventions

Our Intervention includes a 60-90 minute educational seminar, entitled "Destination: Transplant", featuring "live" speakers, delivered to small groups of Black kidney transplant candidates and their family and friends. Topics include: 1) basic facts about Chronic Kidney Disease (CKD), transplant, and the waiting list; 2) the experience of receiving a LDKT transplant (by a Black LDKT recipient); 3) the experience of serving as a living kidney donor (by a Black living kidney donor); and 4) strategies to increase the chances of getting a transplant sooner. Participants receive monthly mailed, written information for 9 months and a follow-up phone call from a transplant educator, 3 months after attending the seminar.

Additional education

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-reported as Black or African-American
  • years of age or older
  • active on kidney transplant waiting list at Saint Barnabas Medical Center

You may not qualify if:

  • limited English proficiency
  • unable or unwilling to provide informed consent
  • unable to complete in-person and telephone questionnaires (including hearing impairment or low vision)
  • lack a working telephone
  • live 150 miles or greater from transplant center
  • enrolled in prior randomized intervention trial, NCT01261910, at our center
  • currently already scheduled to receive a live donor kidney transplant
  • active on the simultaneous pancreas-kidney transplant waiting list

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Barnabas Medical Center

Livingston, New Jersey, 07039, United States

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicKidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Francis L Weng, MD, MSCE

    St. Barnabas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2014

First Posted

December 18, 2014

Study Start

December 1, 2014

Primary Completion

February 1, 2018

Study Completion

August 1, 2018

Last Updated

December 27, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

There are no plans to share individual participant data.

Locations